These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29569527)

  • 1. Future directions in pharmacogenomics discovery in cardiovascular disease.
    Friede KA; Voora D
    Pharmacogenomics; 2018 Apr; 19(5):375-377. PubMed ID: 29569527
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualising HIV treatment--pharmacogenetics and immunogenetics.
    Telenti A; Aubert V; Spertini F
    Lancet; 2002 Mar; 359(9308):722-3. PubMed ID: 11888578
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacogenetics of antiretroviral therapy: a review of studies to date.
    Quirk E; McLeod H; Powderly W
    Clin Infect Dis; 2004 Jul; 39(1):98-106. PubMed ID: 15206060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
    Phillips EJ
    Clin Infect Dis; 2006 Jul; 43(1):103-5. PubMed ID: 16758425
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics of antimicrobial agents.
    Aung AK; Haas DW; Hulgan T; Phillips EJ
    Pharmacogenomics; 2014; 15(15):1903-30. PubMed ID: 25495412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
    Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
    Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of abacavir hypersensitivity: A systematic review and meta-analysis of the association with HLA-B*57:01.
    Sousa-Pinto B; Pinto-Ramos J; Correia C; Gonçalves-Costa G; Gomes L; Gil-Mata S; Araújo L; Delgado L
    J Allergy Clin Immunol; 2015 Oct; 136(4):1092-4.e3. PubMed ID: 25934581
    [No Abstract]   [Full Text] [Related]  

  • 8. Large lymphadenopathies complicating the abacavir hypersensitivity reaction.
    García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS
    AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059
    [No Abstract]   [Full Text] [Related]  

  • 9. Warning against rechallenge with abacavir.
    AIDS Patient Care STDS; 1998 Mar; 12(3):229. PubMed ID: 11361938
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
    Lucas A; Nolan D; Mallal S
    J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
    Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
    Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abacavir hypersensitivity reaction.
    AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientists find some genes a bad omen for anti-HIV drug.
    Stephenson J
    JAMA; 2002 Apr; 287(13):1637. PubMed ID: 11926874
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 16. Current trends in screening across ethnicities for hypersensitivity to abacavir.
    Rodriguez-Nóvoa S; Soriano V
    Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir and increased risk of myocardial infarction.
    Post FA; Campbell LJ
    Lancet; 2008 Sep; 372(9641):803; author reply 804-5. PubMed ID: 18774412
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactions.
    Thygesen H; Su TL; Whitehead J; Bowman C
    J Biopharm Stat; 2011 Jan; 21(1):111-24. PubMed ID: 21191858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.
    Dello Russo C; Lisi L; Lofaro A; Di Giambenedetto S; Federico B; Madeddu G; Salerno M; Mura MS; Pirazzoli A; de Luca A; Cauda R; Navarra P
    Pharmacogenomics; 2011 Apr; 12(4):567-76. PubMed ID: 21521028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity related to abacavir in two members of a family.
    Peyrieère H; Nicolas J; Siffert M; Demoly P; Hillaire-Buys D; Reynes J
    Ann Pharmacother; 2001 Oct; 35(10):1291-2. PubMed ID: 11675863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.